SCHEMBL13338690

SCHEMBL13338690

CC(C)N(c1ccc(-c2ccccc2)cc1)c1ccc2c3c(cccc13)-c1ccccc1-2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
PABPC1 P11940 3/20 0.41
KDM4E B2RXH2 2/20 0.41
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
HTT P42858 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
NPC1 O15118 2/20 0.38
LMNA P02545 2/20 0.38
RAB9A P51151 2/20 0.38
APAF1 O14727 1/20 0.38
THRB P10828 1/20 0.38
XBP1 P17861 1/20 0.38
PTBP1 P26599 1/20 0.38
GALK1 P51570 1/20 0.38
BLM P54132 1/20 0.38
SMAD3 P84022 1/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13338413 0.91 MAPT (0.45) MAPTSMN1; SMN2PABPC1KDM4EKMT2A
SCHEMBL13338517 0.87 KDM4E (0.45) MAPTSMN1; SMN2PABPC1KDM4EKMT2A
SCHEMBL13338368 0.85 MAPT (0.50) MAPTSMN1; SMN2PABPC1KDM4EKMT2A
SCHEMBL13338554 0.83 KDM4E (0.39) MAPTSMN1; SMN2PABPC1KDM4EKMT2A
SCHEMBL13338809 0.83 KEAP1 (0.42) MAPTSMN1; SMN2PABPC1KDM4EKMT2A
SCHEMBL13338691 0.82 CYP1A2 (0.33) MAPTKDM4EHTTTHRBALDH1A1
SCHEMBL13367605 0.81 MEN1 (0.43) MAPTSMN1; SMN2PABPC1KDM4EKMT2A
SCHEMBL13338682 0.81 ALDH1A1 (0.41) MAPTSMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL13338456 0.81 CASP1 (0.41) MAPTSMN1; SMN2PABPC1KDM4EKMT2A
SCHEMBL23546630 0.80 CRHBP (0.42) MAPTSMN1; SMN2PABPC1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 MAPT 3478/4885SMN1; SMN2 3091/4885PABPC1 4474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.